Low-dose clofarabine in combination with a standard remission induction in patients aged 18-60 years with previously untreated intermediate and bad-risk acute myeloid leukemia or high-risk myelodysplastic syndrome: combined phase I/II results of the EORTC/GIMEMA AML-14A trial

Thumbnail
Fulltext:
169738.pdf
Size:
348.7Kb
Format:
PDF
Description:
Publisher’s version
Download
Publication year
2017
Author(s)
Selleslag, D.
Suciu, S.
Meloni, G.
Muus, P.
Halkes, C.J.
Venditti, A.
Ramadan, S.M.
Pruijt, H.
Meert, L.
Vignetti, M.
Marie, J.P.
Wittnebel, S.
Witte, T.J. de
Amadori, S.
Willemze, R.
Baron, F.
Source
Haematologica, 102, 2, (2017), pp. e47-e51
ISSN
DOI
Publication type
Article / Letter to editor
Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/169738   https://hdl.handle.net/2066/169738
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.